Europe — EMA
Oximezin (Cefotaxime)
Cefotaxime, the active ingredient in Oximezin, is a cephalosporin presented as a unknown/unknown for injection use. It treats severe bacterial infections and is used in hospital settings for patients of all ages.
Request sourcing
What is Cefotaxime?
Cefotaxime, the active ingredient in Oximezin, is a cephalosporin presented as a unknown/unknown for injection use. It treats severe bacterial infections and is used in hospital settings for patients of all ages. GNH USA supplies Oximezin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
GNH USA supplies Oximezin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Cefotaxime used for?
Cefotaxime is a broad‑spectrum β‑lactam antibiotic that acts on bacterial cell‑wall synthesis.
- Bacterial meningitis: Reduces the ... ... ... ... ... ... ... ... … … … … … … … - ... … ... ... … … … ... … ... … … … … - ...
What are the side effects of Cefotaxime?
Common ... … … … .... … ...
What precautions apply to Cefotaxime?
… … ...
What does Cefotaxime interact with?
Major
Product details
Related products

Cefotaxime 500 mg/1
Cefotaxime · 500 mg

Cefotaxime 1 g/1
Cefotaxime · 1 g

Cefotaxime 2 g/1
Cefotaxime · 2 g

Cefotaxime 10 g/1
Cefotaxime · 10 g